Skip to content
ClinCalc Pro
Menu
Pancreatic Enzyme Supplement

Pancreatin (Pancreatic Enzyme Replacement Therapy — PERT)

Brand names: Creon, Nutrizym, Pancrease HL

Pancreatin provides pancreatic enzyme replacement therapy and is used to treat exocrine pancreatic insufficiency, for example in cystic fibrosis, chronic pancreatitis and after pancreatic surgery.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It supplies the digestive enzymes lipase, amylase and protease, replacing deficient pancreatic secretions to aid the breakdown and absorption of fat, carbohydrate and protein.

Prescribing in practice

  • Very high doses of high-strength preparations have been linked to fibrosing colonopathy, particularly in children with cystic fibrosis, so the total enzyme intake should be kept within recommended limits.
  • Capsules and their granules should be taken with meals and snacks and not chewed, so the enzymes are released in the small bowel.
  • Ensure adequate hydration, as inadequate fluid intake may contribute to bowel complications.

Monitoring

Monitor nutritional status, growth in children and control of steatorrhoea, adjusting the dose to symptoms and dietary fat intake.

Counselling the patient

  • Advise patients to take the enzymes with every meal and snack and to swallow capsules whole, or sprinkle the granules onto soft acidic food without chewing.
  • Explain that the dose may need adjusting with the fat content of meals and to report persistent diarrhoea or abdominal pain.

Evidence & guidelines

Pancreatic enzyme replacement therapy is the standard of care for exocrine pancreatic insufficiency, supported by NICE guidance on cystic fibrosis and pancreatitis.

Reference: Cystic Fibrosis Trust — PERT Guidelines; SPC Creon; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.